Cyclofenil

This classification denotes an antiestrogen with the molecular formula C23H24O4, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier J468V64WZ1, chemically known as 4,4-(cyclohexylidenemethylene)diphenol diacetate ester but generally known as cyclofenil, which bears US NIH Compound Identifier 2898. European Medicines Agency schedules Cyclofenil in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06852MIG. The term CYCLOFENIL is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 31, No10, 1977, List 17). World Health Organization schedules cyclofenil in its Anatomical Therapeutic Chemical (ATC) Classification. CYCLOFENIL is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule cyclofenil under HS 29153980 and SITC 51372. As of Q4 2014, CYCLOFENIL remains the US FDA Preferred Term for this commodity. Cyclofenil bears US NLM identifiers UMLS ID C0010560 and NCI Concept Code C78030. SMILES: O(C1CCC(C(=C2\CCCCC2)/C2CCC(OC(=O)C)CC2)CC1)C(=O)C.